Please login to the form below

Not currently logged in
Email:
Password:

Astellas Pharma Europe appoint new senior director, market access

Dr Susan Wood was previously senior brand director of the company’s pain management franchise 

Dr Susan Wood, Astellas Pharma 

Astellas Pharma Europe, the European subsidiary of the Tokyo-based company, has promoted Dr Susan Wood to senior director of market access.

Wood joined the company in 2008, where she was most recently senior brand director for the company's pain management franchise, which she held for three years.

During this time she led the launch of a peripheral neurotic pain treatment Qutenza (capsaicin), which involved an integrated market access approach at an early stage of strategic planning.

Commenting on the appointment, Ken Jones, president and CEO of Astellas Pharma Europe, said: “Sue will be working closely with our affiliates to drive the market access strategy across the Astellas Europe organisation in our key therapeutic areas, focusing on developing evidence-based models from the early stages of R&D until the mature stages of the product lifecycle.”

In her new role Wood will focus on developing the company's market access activities and will report to Kay Drake, vice president marketing.

“I am very much looking forward to the challenge of supporting the company to achieve its strategic objectives,” said Wood.

“Astellas Pharma Europe has recently launched its oncology franchise, we are expecting some 11 products to be in launch or early-growth phase in the next three years.

“We are growing fast in anti-infectives, with the recently launched anti-infective Dificlir, the first new treatment in 50 years for clostridium difficile (C.diff), and we continue to affirm our category leadership in transplantation and urology.”

Wood has more than 13 years' experience in international pharmaceutical marketing, with a particular focus on strategy. Prior to joining Astellas, she held management roles with Hoffman-La Roche, Biogen and Sanofi Pasteur.

14th August 2012

From: Marketing, Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...

Infographics